Kura Oncology, Inc.

Overview

Kura Oncology, Inc. is a biopharmaceutical company focused on the development of precision medicines for the treatment of cancer. The company leverages its expertise in oncology to target the genetic drivers of cancer and offer personalized treatment options.

Therapeutic areas

API / Drug Master Files

Kura Oncology, Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TIPIFARNIB (R115777) DRUG SUBSTANCEActive2004-07-14

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Kura Oncology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.